Trials / Completed
CompletedNCT00479024
Follow-up Study to Previous CARE Trial
CARE (Visipaque 320 and Isovue 370 in Cardiac Angiography in REnally Impaired Patients); FOLLOW-UP STUDY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 294 (actual)
- Sponsor
- Bracco Diagnostics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine comparative 1-year outcomes in renally impaired patients who previously underwent cardiac angiography with Isovue®-370 or Visipaque™ 320 as part of the IOP-104 trial protocol and were evaluable for determination of post-contrast significant renal injury (defined as \>25% increase in SCr or \>25% increase in cystatin C).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | iodinated contrast agent | iodinated contrast agent either 370 stength of iopamidol or 320 strength of visipaque |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-12-01
- Completion
- 2008-04-01
- First posted
- 2007-05-25
- Last updated
- 2009-09-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00479024. Inclusion in this directory is not an endorsement.